AIM ImmunoTech Inc receives required Ethics Committee approval in the Netherlands to commence its Phase 1 clinical study on the safety of its drug Ampligen as an intranasal therapy proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.